Categories: News

Alignment Healthcare to Announce Second Quarter 2022 Financial Results and Host Conference Call Thursday, Aug. 4, 2022

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ORANGE, Calif., July 06, 2022 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a tech-enabled Medicare Advantage company, will release its second quarter 2022 financial results on Thursday, Aug. 4, 2022, after market close. Following the release, the company will host a conference call to review its financial results at 6 p.m. EDT.

Conference Call Details
Participants may pre-register for the conference call at the following link:
https://register.vevent.com/register/BI2c25ae8938554eedb99f028a75720193

Upon registration, participants will receive conferencing details, including the dial-in number and a unique participant ID. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web link and will remain available for approximately 12 months.

About Alignment Healthcare
Alignment Healthcare is a consumer-centric platform delivering customized health care in the United States to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. The company provides partners and patients with customized care and service where they need it and when they need it, including clinical coordination, risk management and technology enablement. Alignment Healthcare offers health plan options through Alignment Health Plan, and also partners with select health plans to help deliver better benefits at lower costs.

Investor Contact
Harrison Zhuo
hzhuo@ahcusa.com

Media Contact
Maggie Habib
mPR, Inc. for Alignment Healthcare
alignment@mpublicrelations.com

Staff

Recent Posts

Red Light Holland Provides Timing for 2025 Audited Year-End Results and Announces Live Q&A

Red Light Holland will release its 2025 audited year-end results, prior to the opening of…

1 hour ago

AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

Trial Investigates Use of Auryon Atherectomy System in Cases with Challenging Below-the-Knee BlockagesLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics,…

2 hours ago

AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

Trial Investigates Use of Auryon Atherectomy System in Cases with Challenging Below-the-Knee BlockagesLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics,…

2 hours ago

Britannia Life Sciences Inc. Announces $10 Million Debenture Offering to Provide Investor Access to Asset-Backed Loan Portfolio

Toronto, Ontario--(Newsfile Corp. - July 28, 2025) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia"…

2 hours ago